Navigation Links
ChromaDex Appoints Curtis Lockshin, Ph.D., to its Board of Directors
Date:4/4/2011

>

Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to: the ability to market, produce and sell the referenced ingredients; risks relating to product and customer demand, market acceptance of our products; the effect of economic conditions both nationally and internationally; the ability to protect our intellectual property rights; the impact of any litigation or infringement actions brought against us; competition from other providers and products; risks in product development; our ability to raise capital to fund continuing operations; the ability to complete transactions; and other factors discussed from time to time in the company's Securities and Exchange Commission filings. The company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

Investor Inquiries
Liviakis Financial Communications, Inc.
John M. Liviakis, President
415-389-4670
John@Liviakis.com

ChromaDex Contact
Jenny Robles
949-419-0288
jennyr@chromadex.com

Media Contact
Carolyn Hawley
Canale Communications
619-849-5375
carolyn@canalecomm.com


'/>"/>
SOURCE ChromaDex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ChromaDex Names Pharmaceutical Industry Veteran William F. Spengler as President
2. ChromaDex Commences a Clinical Trial on pTeroPureā„¢ Pterostilbene
3. ChromaDex Launches pTeroPure Pterostilbene
4. ChromaDex Announces 2008 Year End Financial Results
5. ChromaDex Announces Second Quarter 2008 Financial Results
6. BioStorage Technologies Appoints New Director of Business Development for European Operations
7. Access Pharmaceuticals Appoints Industry Executive Anthony Mottola as Vice President of Managed Care and Market Access
8. SeraCare Life Sciences Appoints Sean OConnor as Vice President of Sales and Marketing
9. Genesis Biopharma Appoints William H. Andrews Ph.D. to Board of Directors
10. Laureate Biopharma Appoints Ann M. Daus, Ph.D. Vice President, Quality
11. OncoSec Medical Appoints Punit Dhillon as President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... PA (PRWEB) June 18, 2013 Demanding ... Ball Lenses engineered of synthetic Sapphire and Glass Ball ... sizes from Swiss Jewel Company , of Philadelphia ... by expanding and collimating the light beams without the ... optical clarity and natural durability (9 mohs) make it ...
(Date:6/18/2013)... , June 18, 2013 ... the release of the HELM biomolecular representation standard ... source MIT licence. HELM (Hierarchical Editing ... wide range of biomolecules (e.g. proteins, nucleotides, antibody ... small-molecule and sequence-based informatics methodologies impractical or unusable. ...
(Date:6/18/2013)... , June 18, 2013 Mapi ... (APIs), generic and innovative intermediates, and finished dosage forms based ... has been granted a United States ... Europe for the oral treatment of ... is titled Intermediate Compounds and Processes for the Preparation ...
(Date:6/18/2013)... THE WOODLANDS, Texas , June 18, 2013 ... LXRX ), a biopharmaceutical company focused on ... that John Northcott has joined the ... strategy, and operations. Mr. Northcott brings extensive commercial ... on-market commercialization across a variety of therapeutic areas. ...
Breaking Biology Technology:Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
... applaud Senator Ted Kanavas for his desire to align best ... to see the senator refer to the Sarbanes-Oxley Act of ... at this concept a little closer. President Bush signed Sarbox ... corporate accounting scandals, most notably Enron and WorldCom. , ,Sarbox ...
... in the field and navigating at the helm of several ... (which is located in Woodridge, Ill. across from Argonne ... advance his drug discovery company. , ,Following a six-month ... the next few weeks with financial adviser Legg Mason ...
... with Congresswomen Tammy Baldwin at her Madison office about ... for technology development, as well as how we can ... best known for her unwavering commitment to farmers, senior ... is emerging as a leader in the Wisconsin technology ...
Cached Biology Technology:My View - State Government Needs Integrity To Build Investor Confidence 2Advanced Life Sciences to Hit the Road For $30 Million in Funding 2Advanced Life Sciences to Hit the Road For $30 Million in Funding 3Advanced Life Sciences to Hit the Road For $30 Million in Funding 4WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 2WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 3WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 4WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 5WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 6
(Date:6/17/2013)... BOSTON , June 17, 2013 ... prolific, the need to secure them grows exponentially, ... the latest report from Heavy Reading Insider ... from Heavy Reading ( www.heavyreading.com ). ... Smartphones examines the market for biometric authentication on ...
(Date:6/17/2013)... The AGA Research Foundation and Horizon Pharma further ... gastroenterology with the 2013 AGA-Horizon Pharma Fellow Abstract Prizes ... "In its third year, this competition continues to grow ... promising careers in basic and clinical research," said Nicholas ... Foundation. "We are extremely proud of all that these ...
(Date:6/17/2013)... French . A ... Alzheimer,s disease can be reversed with treatment. The study by ... Neuro, at McGill University and at Universit de Montral found ... brain of mice with advanced Alzheimer,s disease (AD) recovers memory ... of Neuroinflammation in May, also suggest an underlying mechanism ...
Breaking Biology News(10 mins):Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3Horizon Pharma Abstract Prizes recognize promising fellows and students 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2
... cancer drug asparaginase fails to help cure some children ... certain cells in the bone marrow counteract the effect ... Children's Research Hospital. , The researchers showed that ... niche for leukemic cells by releasing large amounts of ...
... Using a biochemical version of a computer chip, a team ... related to the mating habits of yeast cells. ... Publication of the journal Nature, shed new light on the ... from the environment through a process called signal transduction. That ...
... Harvard School of Public Health (HSPH) finds that polio vaccination ... of over $180 billion, even without including the large, intangible ... to retrospectively demonstrate the enormous benefits of polio vaccination appears ... December 2006 issue of Risk Analysis. , The history of ...
Cached Biology News:Leukemic cells find safe haven in bone marrow 2Leukemic cells find safe haven in bone marrow 3Microfluidic chip helps solve cellular mating puzzle 2Microfluidic chip helps solve cellular mating puzzle 3Billions of dollars saved in US by polio vaccination 2
Reacts with the 80 kDa fragment of the M-chain of human merosin....
Goat polyclonal to Rabenosyn 5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: ELKHTLAKQKGGTD, corresponding to C terminal amino acids 771-784 of Human Rabenosyn 5. Entr...
Acetyl CoA Carboxylase Antibody...
Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...
Biology Products: